Mobile Menu - OpenMobile Menu - Closed


Trump’s Art of the Deal for Big Pharma, Not Patients

July 24, 2020

***For Immediate Release***

Press release header


July 24, 2020

Contact: Kate Stotesbery



Trump's Art of the Deal for Big Pharma, Not Patients

Washington, D.C. – Following President Trump’s announcement of four executive orders concerning prescription drug prices, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, issued the following statement:

“After 3 ½ years of tweets and bluster, Trump once again delays action to appease his pals at Big Pharma. Instead of real relief from prescription price gouging, Trump lowers prices for nobody this year. He offers only modest orders recycling dormant proposals and a previously rejected, Big Pharma-promoted rebate rule, which will only increase both premiums and government spending. He remains silent on the 2017 request by fifty House members that he use existing authority to lower prices on drugs developed with taxpayer money—such as the many vaccines and treatments currently being developed for COVID-19 using billions of taxpayer dollars.”


 Follow Congressman Doggett

Facebook | Twitter: @RepLloydDoggett  | Instagram: @RepLloydDoggett